The SEQUEL brand, founded in 2015 (United States), from 7 sister brands and 2617 competing brands. SEQUEL is a brand of Pacific Biosci. of California, listed on the stock exchange of New York. SEQUEL is part of the Medical Diagnostics & Research activity sector.
Investment simulator :
Portfolio valuation
Pacific Biosci. of California
(SEQUEL)
over 5 years*
USD 0.29